Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors

NCT05851092 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: HRS-2189 Tablets

Sponsor

Shandong Suncadia Medicine Co., Ltd.